コンテンツにジャンプ

トップページ > 各部紹介 > データサイエンス研究部 > 業績論文 > 2022年

2022年

英文

  1. Ito Y, Katanoda K, Yamamoto S, Hamajima N, Mochizuki Y, Matsuo K. Trends in smoking prevalence and attitude toward tobacco control among members of the JCA in 2004-2017. Cancer Sci. 2022 Apr;113(4):1542-1547. [PubMed]
  2. Kanehara R, Goto A, Watanabe T, Inoue K, Taguri M, Kobayashi S, Imai K, Saito E, Katanoda K, Iwasaki M et al. Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer. J Diabetes Investig. 2022;13(10):1771-1778.[PubMed]
  3. Nguyen PT, Katanoda K, Saito E, Hori M, Nakayama T, Matsuda T. Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach. Int J Cancer. 2022 Jul 1;151(1):20-32. [PubMed]
  4. Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, Kantilal K, Katanoda K, Kenis C, Lu-Yao G et al. International trends in cancer incidence in middle-aged and older adults in 44 countries. J Geriatr Oncol. 2022 Apr;13(3):346-355. [PubMed]
  5. Tanaka S, Palmer M, Katanoda K. Trends in cervical cancer incidence and mortality of young and middle adults in Japan. Cancer Sci. 2022 May;113(5):1801-1807. [PubMed]
  6. Tanaka H, Nusselder WJ, Kobayashi Y, Mackenbach JP. Socioeconomic inequalities in self-rated health in Japan, 32 European countries and the United States: an international comparative study [published online ahead of print, 2022 May 10]. Scand J Public Health. 2022;14034948221092285.[PubMed]
  7. Dhungel B, Wada K, Tanaka H, Gilmour S. Time to update the Japanese standard population for comparing mortality rates  Arch Public Health. 2022 Jun 6;80(1):153. [PubMed]
  8. Y. K. Lau, S. Okawa, R. Meza, K. Katanoda and T. Tabuchi.: Nicotine dependence of cigarette and heated tobacco users in Japan, 2019: a cross-sectional analysis of the JASTIS Study. Tob Control. 2022 Aug;31(e1):e50-e56  [PubMed]
  9. M. Inoue-Choi, N. D. Freedman, E. Saito, S. Tanaka, M. Hirabayashi, N. Sawada, S. Tsugane, Y. Usui, H. Ito, C. Wang, A. Tamakoshi, T. Takeuchi, Y. Kitamura, M. Utada, K. Ozasa, Y. Sugawara, I. Tsuji, K. Wada, C. Nagata, T. Shimazu, T. Mizoue, K. Matsuo, M. Naito, K. Tanaka, K. Katanoda, M. Inoue, Development Research Group for the and Japan Evaluation of Cancer Prevention Strategies in Japan. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. Int J Epidemiol. 2022 Aug 10;51(4):1276-1290.  [PubMed]
  10. Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Correction to: Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. Int J Epidemiol. 2022 Aug 10;51(4):1355.[PubMed]
  11. M. Ichikawa, H. Inada, K. Katanoda and S. Nakahara. Trend in alcohol-related crashes before and after the introduction of mandatory breath testing among commercial truck drivers [published online ahead of print, 2022 Aug 13]. J Epidemiol. 2022;10.2188/jea.JE20220054.[PubMed]
  12. Smith J, Togawa K, Dresler C, Hawari F, Zain ZM, Stewart B, Warren GW, Sitas F. Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology. Cancer Epidemiol. 2022;79:102210. [PubMed]
  13. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machelek D, Ml Brotherton J, Hocking JS. Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis. Vaccine. 2022 Sep 29;40(41):5971-5996. [PubMed]
  14. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan[published online ahead of print, 2022 Sep 13]. Tob Control. [PubMed]
  15. Nguyen PT, Saito E, Katanoda K. Long-Term Projections of Cancer Incidence and Mortality in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2054: An Empirical Validation Approach. Cancers (Basel). 2022;14(24):6076. Published 2022 Dec 9. [PubMed]
  16. Katagiri R, Tabuchi T, Katanoda K. Socioeconomic and sociodemographic factors associated with food expense insufficiency during the COVID-19 pandemic in Japan. PLoS One. 2022;17(12):e0279266. Published 2022 Dec 15.[PubMed]
  17. Ozasa K, Katanoda K. A Special Issue on Fukushima Has Been Released a Decade After the Great East Japan Earthquake. J Epidemiol. 2022;32(Suppl_XII):S1-S2.[PubMed]
  18. Yoshida S, Okubo R, Katanoda K, Tabuchi T. Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation: the Japan COVID-19 and Society Internet Survey. Fam Pract. 2022;39(5):883-890.[PubMed]
  19. Kurokawa T, Ozaki A, Bhandari D, Kotera Y, Sawano T, Kanemoto Y, Kanzaki N, Ejiri T, Saito H, Kaneda Y, Tsubokura M, Tanimoto T, Katanoda K, Tabuchi T. Association between COVID-19 incidence and postponement or cancellation of elective surgeries in Japan until September 2020: a cross-sectional, web-based survey. BMJ Open. 2022 Oct 10;12(10):e059886. [PubMed]
  20. Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, Ishihara J, Takachi R, Nagata C, Saito E, Goto A, Ueda K, Tanaka J, Hori M, Matsuda T; Cancer PAF Japan Collaborators. Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med. 2022 Feb 28;4(1):26-36. [PubMed]
  21. Takenobu K, Yoshida S, Katanoda K, Kawakami K, Tabuchi T. Impact of workplace smoke-free policy on secondhand smoke exposure from cigarettes and exposure to secondhand heated tobacco product aerosol during COVID-19 pandemic in Japan: the JACSIS 2020 study. BMJ Open. 2022;12(3):e056891. Published 2022 Mar 18.[PubMed]
  22. Kitajima T, Schüz J, Morita A, Ikeda W, Tanaka H, Togawa K, Gabazza EC, Taki M, Toriyabe K, Ikeda T, Sokejima S. Measurement of intermediate frequency magnetic fields generated by household induction cookers for epidemiological studies and development of an exposure estimation model. Int J Environ Res Public Health. 2022;19(19): 11912.[PubMed]
  23. Kuurdor ED, Tanaka H, Kitajima T, Amexo JX, Sokejima S. Social capital and self-rated health: a cross-sectional study among rural Japanese working residents. Int J Environ Res Public Health. 2022;19(21): 14018.[PubMed]

和文

  1. 片野田耕太 . 新 高等保健体育 指導ノート 保健編 1現代社会と健康. 13 喫煙と健康.東京, 大修館書店: 216-229,2022
  2. 伊藤 ゆり, 堀 芽久美, 福井 敬祐, 太田 将仁, 中田 佳世, 杉山 裕美, 伊藤 秀美, 大木 いずみ, 西野 善一, 宮代 勲, 片野田 耕太, 柴田 亜希子, 松田 智大.20年間でがん患者の生存率は向上したか?6府県の住民ベースのがん登録による検討. Journal of Epidemiology 32(Suppl.1) 90-90, 2022
  3. 片野田 耕太.【UP DATE 新型タバコ-COVID-19も絡むタバコ問題の今】UP DATE 最新タバコ研究. 公衆衛生 86(2) 169-176 ,2022
  4. 奥山絢子, 片野田耕太, 田淵貴大., 基礎疾患保持者の新型コロナウイルス感染症に対する認識と受療状況：2020年8月～9月の状況についてのアンケート調査：日本公衆衛生学雑誌, 69(3) 204-214, 2022
  5. 北原 慈和, 長井 万恵, 井手野 由季, 片野田 耕太, 岩瀬 明, 林 邦彦. 日本ナースヘルス研究(JNHS)からみた更年期について. 糖尿病・内分泌代謝科編集委員会 編 54(3) 351-357, 2022
  6. 福井敬祐, 伊藤ゆり, 片野田 耕太. 都道府県別にみるがん年齢調整死亡率の推移予測ツールの開発. 厚生の指標 69(5) 1-6, 2022
  7. 片野田 耕太.【日常生活に潜む健康被害】家庭内の喫煙による家族への影響. 保健の科学 64(10) 657-663, 2022
業績論文
2025年
2024年
2023年
2022年
2021年
2020年
2019年
2018年
2017年